Kedrion Biopharma sponsors NBDF conference in Atlanta, 2024

Kedrion Biopharma Inc. is sponsoring the National Bleeding Disorders Foundation's 76th Annual Bleeding Disorders Conference, taking place from September 12-14, 2024, in Atlanta, Georgia. This event aims to unite individuals with bleeding disorders, their families, healthcare professionals, and researchers to discuss advancements in research and treatment. The conference will feature educational sessions, workshops, and networking opportunities focused on living with bleeding and clotting disorders, as well as ongoing research and advocacy efforts. Kedrion's involvement highlights its commitment to the bleeding disorders community, with plans to host various activities to engage attendees. Notable events include a Campfire presentation on the Hereditary Factor X in Americas survey, the 2nd Annual Plasminogen Deficiency Roundtable, and The Ultra Rare Networking Hour, which will provide a platform for individuals with ultra-rare disorders to connect and share experiences. The conference also serves as an opportunity for Kedrion to connect with patients suffering from Plasminogen Deficiency Type 1 and Hereditary Factor X Deficiency, both of which are rare and potentially life-threatening conditions. The company will share insights into therapy developments and ongoing research efforts in these areas, reinforcing its dedication to improving patient care. Bob Rossilli, CCO and US General Manager of Kedrion, emphasized the company's mission to amplify the voices of patients with rare diseases. The participation in the NBDF Conference reflects Kedrion's ongoing commitment to enhancing the lives of individuals affected by these conditions, fostering a sense of community and support among attendees.